Powered by: Motilal Oswal

News

1 person globally acquires new genital herpes infection every second: WHO At least one person each second, or 42 million people annually worldwide is estimated to acquire a new genital herpes infection, according to new estimates by the World Health Organization on Wednesday.  It showed that about 846 million people or more than 1 in 5 people aged between 15 and 49 are living with genital herpes infections. Herpes simplex virus (HSV), known as herpes, is a common infection that can cause painful blisters or ulcers. It primarily spreads by skin-to-skin co...
1 person globally acquires new genital herpes infection every second: WHO
1 person globally acquires new genital herpes infection every second: WHO
Source: IANS
2024-12-11 11:02:22 am
India will strengthen global health efforts: PM Narendra Modi to WHO chief `Tulsi Bhai` India will work towards efforts to boost global health, said Prime Minister Narendra Modi on Tuesday while pledging his support to World Health Organisation chief Dr. Tedros Adhanom Ghebreyesus, who he addresses as ‘Tulsi Bhai’.  He said this in response to Ghebreyesus’ post on X, thanking PM Modi and others for their support and contributions during the first-ever WHO Investment Round held in Brazil. The Prime Minister said that India is actively working in the h...
India will strengthen global health efforts: PM Narendra Modi to WHO chief `Tulsi Bhai`
India will strengthen global health efforts: PM Narendra Modi to WHO chief `Tulsi Bhai`
Source: IANS
2024-11-20 02:54:14 pm
A healthy India can help add Rs 15 lakh crore to its GDP by 2047 India is in an alarmingly inactive state, raising several health concerns, warns a report on Wednesday, which showed that boosting sports and physical activity in the country can add Rs 15 lakh crore to its GDP by 2047.  The report by Dalberg Advisors, a Global Consulting Firm showed that at least 155 million Indian adults and 45 million adolescents fail to meet the World Health Organization (WHO) guidelines on physical activity. The WHO advises that adults should get at least 150 to ...
A healthy India can help add Rs 15 lakh crore to its GDP by 2047
A healthy India can help add Rs 15 lakh crore to its GDP by 2047
Source: IANS
2024-09-04 04:16:40 pm
Global health organisation hails PMUY LPG scheme for poor  Families in Indian villages switching to exclusive use of LPG would save more than 1,50,000 lives a year due to reduction in both indoor and outdoor pollution that arises from ‘chulha (wood/coal stove)’ smoke in household kitchens, according to a study by global public health organisation Vital Strategies.   The report comes out strongly in favour of the Pradhan Mantri Ujjwala Yojana (PMUY) stating that the subsidies to provide LPG to poor families were justified on ...
Global health organisation hails PMUY LPG scheme for poor
Global health organisation hails PMUY LPG scheme for poor
Source: IANS
2024-08-28 12:30:30 pm
India`s Bharat Biotech launches oral cholera vaccine after positive phase 3 trial Indian vaccine manufacturer Bharat Biotech said on Tuesday its phase 3 trials of an oral cholera vaccine proved that it is safe for public use, and announced a global launch amid supply shortages and an expanding outbreak. The company, which developed Hillchol under license from Singapore-based Hilleman Laboratories, said it is launching the vaccine with a capacity to produce 200 million doses. Bharat Biotech in a release said it plans to bridge a worldwide deficit of 40 million doses p...
India`s Bharat Biotech launches oral cholera vaccine after positive phase 3 trial
India`s Bharat Biotech launches oral cholera vaccine after positive phase 3 trial
Source: Reuters
2024-08-27 01:58:03 pm
Sequent Scientific jumps on receiving WHO prequalification approval for Albendazole API Sequent Scientific is currently trading at Rs. 168.65, up by 11.30 points or 7.18% from its previous closing of Rs. 157.35 on the BSE. The scrip opened at Rs. 166.55 and has touched a high and low of Rs. 175.00 and Rs. 165.00 respectively. So far 372135 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 175.00 on 20-Aug-2024 and a 52 week low of Rs. 86.03 on 13-Sep-2023. Last one week high and low of the scrip stoo...
Sequent Scientific jumps on receiving WHO prequalification approval for Albendazole API
Sequent Scientific jumps on receiving WHO prequalification approval for Albendazole API
Source: Accord Fintech
2024-08-20 10:50:02 am
WHO collaboration boosts India's position as leader in healthcare innovation: Minister The partnership with the World Health Organisation (WHO) for the production of medical devices strengthens India's position as a leader in healthcare innovation, the government has said.  Union Minister of State (Independent Charge) for Science and Technology, Dr Jitendra Singh, said that despite producing indigenous devices, we need to produce them at the required volume to meet the growing demand. Towards this, an MoU has been signed between Sree Chitra Tirunal Institute for ...
WHO collaboration boosts India's position as leader in healthcare innovation: Minister
WHO collaboration boosts India's position as leader in healthcare innovation: Minister
Source: IANS
2024-08-10 09:42:11 am
India's medical devices industry to grow five-fold to $50 bn by 2030: DCGI With proper regulation, India's medical devices industry is estimated to grow five-fold to $50 billion by 2030, said Drug Controller General of India (DCGI) Rajeev Singh Raghuvanshi on Thursday.  He was speaking at a conference on the classification of health products organised by the PHD Chamber of Commerce and Industry in the national capital. The DCGI underlined the benefits of regulation, including quality monitoring and international acceptance, which collectively boost in...
India's medical devices industry to grow five-fold to $50 bn by 2030: DCGI
India's medical devices industry to grow five-fold to $50 bn by 2030: DCGI
Source: IANS
2024-07-25 01:00:26 pm
Zydus Lifesciences soars on getting nod to market Bhava to treat various cancers Zydus Lifesciences is currently trading at Rs. 1163.60, up by 19.00 points or 1.66% from its previous closing of Rs. 1144.60 on the BSE. The scrip opened at Rs. 1139.80 and has touched a high and low of Rs. 1165.45 and Rs. 1122.00 respectively. So far 8396 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1203.20 on 11-Jul-2024 and a 52 week low of Rs. 564.05 on 25-Jul-2023. Last one week high and low of the scrip...
Zydus Lifesciences soars on getting nod to market Bhava to treat various cancers
Zydus Lifesciences soars on getting nod to market Bhava to treat various cancers
Source: Accord Fintech
2024-07-22 10:23:36 am
Stem Cell therapy safe after a spinal cord injury: Study Stem cell therapy can be a safe option for people suffering from hard-to-treat traumatic spinal cord injuries, according to results of a phase 1 clinical trial revealed on Monday. The trial, published by the Mayo Clinic in the US, showed that stem cells that are derived from a patient's own fat are safe and may help in improving sensation and movement for people living with spinal cord injuries and paralysis. "This study documents the safety and potential benefit of stem cells ...
Stem Cell therapy safe after a spinal cord injury: Study
Stem Cell therapy safe after a spinal cord injury: Study
Source: IANS
2024-04-01 04:57:26 pm
Government launches new scheme to upgrade small pharma units to global standards Department of Pharmaceuticals on Monday announced a wider Revamped Pharmaceuticals Technology Upgradation Assistance Scheme in a significant step to help upgrade the technological capabilities of the country’s pharmaceutical industry and ensure its alignment with global standards. The new scheme covers all pharmaceutical manufacturing units with a turnover of less than Rs 500 crore. The revised guideline aims to support the pharmaceutical industry's up-gradation to the Revised...
Government launches new scheme to upgrade small pharma units to global standards
Government launches new scheme to upgrade small pharma units to global standards
Source: Reuters
2024-03-12 09:00:16 am
Smartphones` effect on kids under 10 go beyond eyes, say doctors Smartphone addiction among children under the age of 10, is known to be detrimental for the eyes. However, doctors on Saturday warned that spending excessive time on the device may worsen physical health and cause a host of behavioural issues. According to the World Health Organization (WHO) guidelines, children under five must spend less time watching screens. While the UN health body does not recommend screen time for infants and 1-year-old, those aged 2 years should not be exposed for m...
Smartphones` effect on kids under 10 go beyond eyes, say doctors
Smartphones` effect on kids under 10 go beyond eyes, say doctors
Source: IANS
2024-03-10 11:42:58 am
India gets `Measles & Rubella Champion` award for disease prevention  India has bagged the prestigious 'Measles and Rubella Champion' award for the country's efforts in preventing the highly infectious and contagious diseases. India's Deputy Ambassador to the US, Sripriya Ranganathan, received the award from the Measles and Rubella Partnership at the American Red Cross Headquarters in Washington DC, US, on behalf of the Ministry of Health and Family Welfare, on Wednesday. "India has provided inspiration to regional #measles and ...
India gets `Measles & Rubella Champion` award for disease prevention
India gets `Measles & Rubella Champion` award for disease prevention
Source: IANS
2024-03-08 04:57:50 pm
India`s Serum boosts supply of cervical cancer shots ahead of government`s mass drive Serum Institute of India aims to significantly boost supply of its human papillomavirus (HPV) vaccine as it gears up to provide its shots to the government at cheaper rates for an immunisation campaign this year against the cancer-causing virus. Adar Poonawalla, the CEO of the world's biggest vaccine maker by the number of doses, told Reuters that he expects the vaccine to be a part of the government's programme by year-end. The vaccine, currently available in the private market...
India`s Serum boosts supply of cervical cancer shots ahead of government`s mass drive
India`s Serum boosts supply of cervical cancer shots ahead of government`s mass drive
Source: Reuters
2024-03-04 09:21:58 am
Japan`s Takeda partners with India`s Biological E. to boost dengue vaccine production Japan's Takeda Pharmaceutical will scale up production of its dengue vaccine Qdenga through a partnership with Indian vaccines maker Biological E., the companies said on Tuesday. These doses will be available for governments in endemic countries by 2030 as part of their national immunization programmes. Biological E. will ramp up to a manufacturing capacity of 50 million doses a year, accelerating Takeda's efforts to produce 100 million doses per year within a decade, the compan...
Japan`s Takeda partners with India`s Biological E. to boost dengue vaccine production
Japan`s Takeda partners with India`s Biological E. to boost dengue vaccine production
Source: Reuters
2024-02-27 11:45:45 am
Zydus Lifesciences gains on getting WHO prequalification approval for Miltefosine formulation, API Zydus Lifesciences is currently trading at Rs. 930.90, up by 8.80 points or 0.95% from its previous closing of Rs. 922.10 on the BSE. The scrip opened at Rs. 934.55 and has touched a high and low of Rs. 934.55 and Rs. 922.85 respectively. So far 7505 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 937.00 on 23-Feb-2024 and a 52 week low of Rs. 452.20 on 27-Feb-2023. Last one week high and low of the scrip stood ...
Zydus Lifesciences gains on getting WHO prequalification approval for Miltefosine formulation, API
Zydus Lifesciences gains on getting WHO prequalification approval for Miltefosine formulation, API
Source: Accord Fintech
2024-02-26 10:37:48 am
Concord Biotech gains on getting GMP for unit II of Gujarat facility Concord Biotech is currently trading at Rs. 1463.65, up by 23.40 points or 1.62% from its previous closing of Rs. 1440.25 on the BSE. The scrip opened at Rs. 1441.05 and has touched a high and low of Rs. 1477.15 and Rs. 1441.05 respectively. So far 3957 shares were traded on the counter. The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 1608.20 on 10-Jan-2024 and a 52 week low of Rs. 900.00 on 18-Aug-2023. Last one week high and low of the scrip st...
Concord Biotech gains on getting GMP for unit II of Gujarat facility
Concord Biotech gains on getting GMP for unit II of Gujarat facility
Source: Accord Fintech
2024-02-23 12:21:07 pm
WHO releases 1st-ever guidance on clinical management of diphtheria In a first, the World Health Organization (WHO) has released guidance on the clinical management of diphtheria. While previous available guidance was just an operational protocol, the new guidance followed the rigorous process for developing guidance at WHO. It addresses the use of Diphtheria Antitoxin (DAT) in the treatment of diphtheria. The guidance also includes new recommendations on antibiotics. In patients with suspected or confirmed diphtheria, WHO recommends using macrolide ...
WHO releases 1st-ever guidance on clinical management of diphtheria
WHO releases 1st-ever guidance on clinical management of diphtheria
Source: IANS
2024-02-15 12:15:02 pm
India orders new drug-making standards after overseas deaths Indian pharmaceutical companies must meet new manufacturing standards this year, according to a government notification released on Saturday, although small companies have asked for a delay, citing their debt load. Jolted by a string of overseas deaths linked to Indian-made drugs since 2022, Prime Minister Narendra Modi's government has stepped up scrutiny of pharmaceutical factories to clean up the image of the $50 billion industry. "The manufacturer must assume responsibility...
India orders new drug-making standards after overseas deaths
India orders new drug-making standards after overseas deaths
Source: Reuters
2024-01-06 01:43:56 pm
New WHO screening guidelines can slash cervical cancer death rates by 63%  Cervical cancer death rates in low-to-middle-income countries can be reduced by more than 63 per cent through implementation of updated World Health Organization (WHO) screening guidelines, according to two studies. Researchers at the Daffodil Centre, a joint venture of Cancer Council New South Wales and the University of Sydney, focussed the studies, published in two landmark papers in Nature Medicine, on screening for human papillomavirus (HPV) in the general population in 78 count...
New WHO screening guidelines can slash cervical cancer death rates by 63%
New WHO screening guidelines can slash cervical cancer death rates by 63%
Source: IANS
2023-12-14 06:10:01 pm